| Sheepscot Valley Health Center | |
|
47 Main Street Coopers Mills ME 04341 | |
| (207) 549-7581 | |
| (207) 549-3439 |
| Full Name | Sheepscot Valley Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 47 Main Street, Coopers Mills, Maine |
| Authorized Official Name and Position | Constance R Coggins (PRESIDENT/CEO) |
| Authorized Official Contact | 2078725610 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sheepscot Valley Health Center 47 Main Street Po Box 207 Coopers Mills ME 04341 Ph: (207) 549-7581 | Sheepscot Valley Health Center 47 Main Street Coopers Mills ME 04341 Ph: (207) 549-7581 |
| NPI Number | 1841263118 |
|---|---|
| Provider Enumeration Date | 02/08/2006 |
| Last Update Date | 11/10/2014 |
| Medicare PECOS PAC ID | 5496726523 |
|---|---|
| Medicare Enrollment ID | O20050107000482 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841263118 | NPI | - | NPPES |
| 137970106 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | E58728 (Maine) | Primary |
| Provider Name | Dianne J Raymond |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447276886 PECOS PAC ID: 7416920129 Enrollment ID: I20040907000375 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Lois C Hamel Corson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730135039 PECOS PAC ID: 4880650613 Enrollment ID: I20041203000464 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Ann M. Schwink |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164493136 PECOS PAC ID: 3173575289 Enrollment ID: I20050217000265 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Cynthia R Robertson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316911787 PECOS PAC ID: 7012952278 Enrollment ID: I20050628000443 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Nancy J Cooley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346282233 PECOS PAC ID: 2668484965 Enrollment ID: I20060706000042 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Kathryn G Wistar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1720175599 PECOS PAC ID: 7315944873 Enrollment ID: I20061026000346 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Roy Miller |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700854361 PECOS PAC ID: 9032306212 Enrollment ID: I20101214000796 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Lynn M Murphy |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1437300837 PECOS PAC ID: 5294992335 Enrollment ID: I20120201000724 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Diane Zavotsky |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1023128261 PECOS PAC ID: 8123099215 Enrollment ID: I20141104001286 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Nancy R Glover |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659890473 PECOS PAC ID: 8325304934 Enrollment ID: I20171115001851 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
| Provider Name | Natalie Ledue |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063064491 PECOS PAC ID: 4981935053 Enrollment ID: I20191004000924 |
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago
News Archive
Want your children to be healthier snackers? A new Cornell study finds that serving children combined snacks of vegetables and cheese led them to eat 72 percent fewer calories - and be just as satisfied as those who were served only potato chips.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting - and recounting - the sponges, needles, blades, retractors, and other items used during operations.
POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.
› Verified 5 days ago